KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) — Institutional Holders, Q2 2026 (page 2)

109 institutional investment managers reported a KMTS position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 109. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

KMTS 13F holders ranked 101–109 of 109

Institutional investors reporting a position in KESTRA MEDICAL TECHNOLOGIES, LTD. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
ROTHSCHILD INVESTMENT#101 · 28 sh$712.00+12.0%
NISA INVESTMENT ADVISORS#102 · 20 sh$509.000.0%
IFP Advisors#103 · 19 sh$483.00+5.6%
GAMMA Investing#104 · 10 sh$254.000.0%
Clearstead Advisors#105 · 9 sh$229.00New
SBI Securities , Ltd.#106 · 4 sh$102.000.0%
JPL Wealth Management#107 · 3 sh$77.00New
Global Retirement Partners#108 · 3 sh$76.00—
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#109 · 26,982 sh—-3.1%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.